Jivi® (antihemophilic factor (recombinant), PEGylated-aucl)
for Hemophilia

Jivi is a PEGylated recombinant factor VIII therapy for hemophilia A, used to prevent and control bleeding episodes, including during surgery. It temporarily replaces missing factor VIII to support blood clotting, reducing the risk of prolonged or spontaneous bleeding. Its PEGylation extends its duration in the bloodstream for prolonged protection.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Hemophilia